Concepedia

Sherry Pierce

SP

Statistics

Publications

100

Citations

7.6K

H-Index

48

Active since

1992

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sherry Pierce is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1992–2025

100

Publications

100

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 684 citations · Full text

, , +10

Effective Treatment of Acute Promyelocytic Leukemia With All-<i>Trans</i>-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

Farhad Ravandi, E Estey, Dan Jones et al. · Journal of Clinical Oncology · 2008 · 376 citations · Full text

, , +13

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch et al. · The Lancet Haematology · 2020 · 331 citations · Full text

, , +16

A prognostic score for patients with lower risk myelodysplastic syndrome

Guillermo Garcia‐Manero, J. Shan, S. Faderl et al. · Leukemia · 2007 · 316 citations

, , +12

Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

Yasmin Abaza, Hagop M. Kantarjian, Guillermo Garcia‐Manero et al. · Blood · 2016 · 297 citations · Full text

, , +17

1–5 of 100